Pan J, Deng B, Liu S, et al. Efficacy and safety of CD22-directed CAR-T cell therapy in 15 pediatric refractory or relapsed B acute lymphoblastic leukemia patients. EHA 2018, abstract 832.
CD47-remmer Hu5F9-G4 plus rituximab bij non-hodgkinlymfoom
jan 2019 | Lymfoom